5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 68.51▼ | 68.48▼ | 68.61▼ | 69.30▼ | 65.97▲ |
MA10 | 68.49▼ | 68.63▼ | 68.92▼ | 68.24▲ | 62.56▲ |
MA20 | 68.49▼ | 68.92▼ | 69.34▼ | 66.49▲ | 65.58▲ |
MA50 | 68.53▼ | 69.62▼ | 68.94▼ | 62.35▲ | 67.10▲ |
MA100 | 68.89▼ | 68.86▼ | 67.29▲ | 65.62▲ | 62.95▲ |
MA200 | 69.27▼ | 67.10▲ | 64.64▲ | 67.69▲ | 67.97▲ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.007▲ | -0.037▼ | -0.173▼ | 0.158▲ | 0.649▲ |
RSI | 46.612▼ | 36.132▼ | 38.710▼ | 62.757▲ | 54.810▲ |
STOCH | 57.084 | 28.123 | 38.016 | 74.333 | 78.864 |
WILL %R | -73.529 | -74.216 | -82.547▼ | -35.628 | -18.712▲ |
CCI | -88.779 | -56.081 | -98.007 | 48.274 | 137.524▲ |
Thursday, June 12, 2025 02:43 PM
Incyte (Nasdaq:INCY) today announced that primary results from the Phase 3 POD1UM-303/InterAACT 2 trial of retifanlimab (Zynyz ® ), a humanized monoclonal antibody targeting programmed death ...
|
Thursday, June 12, 2025 09:30 AM
Independent biopharmaceutical company Specialised Therapeutics (ST) is pleased to announce the expansion of its existing supply and distribution agreement with Incyte Biosciences International Sàrl, ...
|
Wednesday, June 11, 2025 02:15 PM
Shares of Incyte Corp. INCY slid 1.74% to $68.85 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the Dow Jones Industrial Average DJIA remaining mostly ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
13/06/25 | 68.495 | 68.955 | 68.09 | 68.46 | 453,567 |
12/06/25 | 68.95 | 69.54 | 68.10 | 69.22 | 1,217,903 |
11/06/25 | 70.12 | 70.36 | 68.79 | 68.85 | 2,203,581 |
10/06/25 | 70.01 | 70.96 | 69.95 | 70.10 | 1,640,486 |
09/06/25 | 68.89 | 69.96 | 68.11 | 69.89 | 2,088,696 |
06/06/25 | 67.78 | 68.98 | 67.62 | 68.77 | 1,719,841 |
05/06/25 | 67.50 | 67.87 | 66.84 | 67.24 | 1,712,763 |
04/06/25 | 67.06 | 68.45 | 66.30 | 67.42 | 1,577,488 |
03/06/25 | 65.12 | 70.97 | 64.72 | 67.11 | 5,339,068 |
02/06/25 | 64.88 | 65.97 | 63.925 | 65.31 | 1,882,997 |
|
|
||||
|
|
||||
|
|